Sofia Agelaki

7.4k total citations
216 papers, 5.0k citations indexed

About

Sofia Agelaki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sofia Agelaki has authored 216 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Oncology, 73 papers in Pulmonary and Respiratory Medicine and 68 papers in Cancer Research. Recurrent topics in Sofia Agelaki's work include Cancer Treatment and Pharmacology (52 papers), Cancer Cells and Metastasis (48 papers) and Lung Cancer Treatments and Mutations (48 papers). Sofia Agelaki is often cited by papers focused on Cancer Treatment and Pharmacology (52 papers), Cancer Cells and Metastasis (48 papers) and Lung Cancer Treatments and Mutations (48 papers). Sofia Agelaki collaborates with scholars based in Greece, United States and Sweden. Sofia Agelaki's co-authors include Dimitris Mavroudis, Vassilis Georgoulias, Galatea Kallergi, Vassilis Georgoulias, Maria A. Papadaki, Kostas Kalbakis, Dimitriοs Mavroudis, Panayiotis A. Theodoropoulos, D. Mavroudis and John Souglakos and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sofia Agelaki

204 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Agelaki Greece 40 3.6k 1.9k 1.5k 1.4k 357 216 5.0k
Alastair Greystoke United Kingdom 28 2.3k 0.6× 1.4k 0.7× 1.3k 0.9× 1.3k 0.9× 349 1.0× 144 3.8k
Tim Ward United Kingdom 26 2.4k 0.7× 1.5k 0.8× 1.0k 0.7× 1000 0.7× 573 1.6× 40 3.5k
Peter Vermeulen Belgium 35 2.3k 0.6× 1.3k 0.7× 776 0.5× 1.4k 1.0× 243 0.7× 79 4.0k
Marius Ilié France 42 3.3k 0.9× 2.4k 1.2× 2.3k 1.6× 1.8k 1.3× 338 0.9× 165 5.9k
Steven Van Laere Belgium 45 2.7k 0.8× 2.5k 1.3× 968 0.7× 2.6k 1.8× 332 0.9× 161 5.6k
Harriet Wikman Germany 41 2.3k 0.6× 2.9k 1.5× 1.3k 0.9× 3.7k 2.6× 355 1.0× 122 6.5k
Xiaoxiang Guan China 38 2.0k 0.6× 1.6k 0.8× 910 0.6× 2.5k 1.8× 260 0.7× 173 4.7k
Nashat Gabrail United States 26 2.3k 0.7× 1.1k 0.5× 788 0.5× 1.6k 1.1× 388 1.1× 154 4.4k
Boe Sandahl Sørensen Denmark 37 2.0k 0.6× 1.6k 0.8× 1.3k 0.9× 2.7k 1.9× 199 0.6× 171 4.9k
David R. Shalinsky United States 27 1.7k 0.5× 1.3k 0.6× 1.0k 0.7× 2.3k 1.6× 215 0.6× 52 4.3k

Countries citing papers authored by Sofia Agelaki

Since Specialization
Citations

This map shows the geographic impact of Sofia Agelaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Agelaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Agelaki more than expected).

Fields of papers citing papers by Sofia Agelaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Agelaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Agelaki. The network helps show where Sofia Agelaki may publish in the future.

Co-authorship network of co-authors of Sofia Agelaki

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Agelaki. A scholar is included among the top collaborators of Sofia Agelaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Agelaki. Sofia Agelaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Groen, Harry J.M., Maarten J. Postma, Εleftherios Ζervas, et al.. (2025). Lung cancer screening with volume computed tomography is cost-effective in Greece. PLoS ONE. 20(3). e0316351–e0316351. 1 indexed citations
3.
4.
Papadaki, Chara, Aristeidis E. Boukouris, Maria Markaki, et al.. (2025). MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non-Small Cell Lung Cancer. Cancers. 17(15). 2504–2504.
5.
Agelaki, Sofia, et al.. (2025). A critical review of explainable deep learning in lung cancer diagnosis. Artificial Intelligence Review. 59(1).
6.
Agelaki, Sofia, Ioannis Boukovinas, Ilias Athanasiadis, et al.. (2024). A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study. Cancer Medicine. 13(3). e6916–e6916. 6 indexed citations
7.
Papadaki, Maria A., Maria Vassilakopoulou, Eleni Papadaki, et al.. (2024). Abstract PO2-15-04: Fas/FasL expression on circulating tumor and immune cells in the peripheral blood of patients with metastatic breast cancer (BC): correlation with clinical outcome. Cancer Research. 84(9_Supplement). PO2–15. 1 indexed citations
8.
Tsiligianni, Ioanna, et al.. (2024). The journey of lung cancer patients from symptoms to diagnosis in Greece. A mixed methods approach. npj Primary Care Respiratory Medicine. 34(1). 5–5. 3 indexed citations
9.
Michaelidou, Kleita, George Papadakis, Antonio Arnau, et al.. (2022). Acoustic Array Biochip Combined with Allele-Specific PCR for Multiple Cancer Mutation Analysis in Tissue and Liquid Biopsy. ACS Sensors. 7(2). 495–503. 10 indexed citations
10.
Papadaki, Maria A., Ippokratis Messaritakis, Oraianthi Fiste, et al.. (2021). Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). International Journal of Molecular Sciences. 22(2). 925–925. 15 indexed citations
11.
Manikis, Georgios C., Georgios Z. Papadakis, Thomas G. Maris, et al.. (2019). Scale-Space DCE-MRI Radiomics Analysis Based on Gabor Filters for Predicting Breast Cancer Therapy Response. 994–1001. 1 indexed citations
12.
13.
Filippidis, George, et al.. (2018). Detection of the T cell activation state using nonlinear optical microscopy. Journal of Biophotonics. 12(3). e201800277–e201800277. 19 indexed citations
14.
Papadaki, Chara, Georgios Markakis, Maria Spiliotaki, et al.. (2018). Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer. Breast Cancer Research. 20(1). 72–72. 64 indexed citations
15.
Kallergi, Galatea, Sofia Agelaki, Maria A. Papadaki, et al.. (2015). Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients. Breast Cancer Research. 17(1). 113–113. 25 indexed citations
16.
Matikas, Alexios, Georgios Lazaridis, & Sofia Agelaki. (2014). Triple-Negative Breast Cancer: One Or More Entities?. SHILAP Revista de lepidopterología. 5(2). 20–31. 1 indexed citations
17.
Kallergi, Galatea, Georgios Konstantinidis, Harris Markomanolaki, et al.. (2013). Apoptotic Circulating Tumor Cells in Early and Metastatic Breast Cancer Patients. Molecular Cancer Therapeutics. 12(9). 1886–1895. 85 indexed citations
18.
Pallis, Athanasios, Sofia Agelaki, S. Kakolyris, et al.. (2008). Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy. Lung Cancer. 62(3). 356–363. 42 indexed citations
19.
Agelaki, Sofia, et al.. (2007). FAK/PI3K activation controls actin reorganization and cell motility. Cancer Research. 67. 3035–3035. 1 indexed citations
20.
Agelaki, Sofia, Charalambos Kouroussis, John Souglakos, et al.. (2001). Vinorelbine-Based Regimens as Salvage Treatment in Patients with Advanced Non-Small Cell Lung Cancer: Two Parallel Multicenter Phase II Trials. Oncology. 60(3). 235–241. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alastair Greystoke Breakdown of academic impact, for papers by Tim Ward Breakdown of academic impact, for papers by Peter Vermeulen Breakdown of academic impact, for papers by Marius Ilié Breakdown of academic impact, for papers by Steven Van Laere Breakdown of academic impact, for papers by Harriet Wikman Breakdown of academic impact, for papers by Xiaoxiang Guan Breakdown of academic impact, for papers by Nashat Gabrail Breakdown of academic impact, for papers by Boe Sandahl Sørensen Breakdown of academic impact, for papers by David R. Shalinsky
Rankless by CCL
2026